Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling
about
Effect of Vitamin D Receptor Activators on Glomerular Filtration Rate: A Meta-Analysis and Systematic ReviewCombination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathySuramin alleviates glomerular injury and inflammation in the remnant kidneyOpposite action of peroxisome proliferator-activated receptor-gamma in regulating renal inflammation: functional switch by its ligandThe world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system.Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells.The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial.Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway.Nuclear NF-κB p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic nephropathy.Vitamin D and inflammatory diseases.Role of mitochondria in paricalcitol-mediated cytoprotection during obstructive nephropathyParicalcitol attenuates lipopolysaccharide-induced inflammation and apoptosis in proximal tubular cells through the prostaglandin E2 receptor EP4.Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system.Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine.Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling.Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 productionUric acid induces renal inflammation via activating tubular NF-κB signaling pathway.Emerging drugs for chronic kidney disease.Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study.Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral stateInhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signalingVitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolismInhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial.Vitamin d receptor activators and clinical outcomes in chronic kidney disease.Nuclear receptors in renal diseaseParicalcitol for secondary hyperparathyroidism in renal transplantation.Treatment with oral paricalcitol in daily clinical practice for patients with chronic kidney disease stage 3-4: a preliminary study.Tubular cell dedifferentiation and peritubular inflammation are coupled by the transcription regulator Id1 in renal fibrogenesis.Cellular and molecular mechanisms of renal fibrosis.The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney DiseaseSonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis.Ligand-dependent actions of the vitamin D receptor are required for activation of TGF-β signaling during the inflammatory response to cutaneous injuryVitamin D: roles in renal and cardiovascular protection.Paricalcitol attenuates lipopolysaccharide-induced myocardial inflammation by regulating the NF-κB signaling pathway.Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction.Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease.The Vitamin D Receptor, Inflammatory Bowel Diseases, and Colon Cancer
P2860
Q26774371-6BCADE3B-8C76-40DC-BF92-84FD3867296AQ28258849-90069378-50D7-4E53-A96F-6427656D3041Q28482696-5135B43F-357D-44BA-A316-C3D9B2BB7854Q28581020-84C5C64D-E3FE-4006-B2A4-2BCDA8ADC3B0Q30426517-7B7DD216-A4FE-4C0A-AFDD-CC1418FB0446Q31117819-FA28AD47-FCEC-4997-8CED-36635E92A54EQ33517923-C8E6E016-10A6-4B25-A0B8-597CCF3FFAACQ33561234-916E11B3-2FFE-4B89-BFCC-BE3BB03D56D3Q33768914-E118731F-DD7F-44ED-9738-B184D68C47E4Q33806322-AE791D09-87CD-4D48-8782-C3CF23E9720AQ33816636-DB10CC6C-B341-453F-BDFC-7C712E8BA30CQ33853492-CEC997EF-401C-4B02-A58C-FD92F3A6FEADQ33979345-C9334F7E-01AE-4C50-81A6-E11F599028FEQ34033348-A9FE0135-7872-4269-B869-A55464E9C895Q34042645-A6EBA889-2381-44E1-975B-369C4EFDA143Q34287169-FE6F95C6-284F-4D5F-AF57-5ADA01181CCBQ34326473-ECD34489-ED85-4D9C-8592-9AA6AAEA3B3BQ34420383-BC465B46-56E7-485B-92F0-BB2A281ED7D0Q34457259-BF9C7CC3-F651-4D7D-B013-B50195A41E84Q34483554-04B14CCC-1676-4E74-B374-81EEC829ED37Q34491713-F5E5146B-448E-4FAC-9D18-2A3E5AD57B51Q34557849-E2CE3310-E517-428A-8548-B2ECEAF1211EQ34606146-FA616353-A574-4D32-89AF-C6BE0097F85FQ34719267-E2BBE7A8-9474-47DC-8ADD-0522447D02B7Q34729973-62B519A6-DB24-4AC9-A18F-034837B58674Q34868253-B63ADC82-308C-4C63-BE5E-D927A1A2AFE3Q35020986-A8D7C093-5EC6-49E1-96A3-B311333F1976Q35120702-AC4C6624-DB33-4779-AF23-9BF22E2E642CQ35550544-A991EB6B-C455-4D6E-872A-E9332B77E60CQ35608454-ECCE3D87-9F0D-443B-90F4-A0F3B504C5E4Q35888486-56205493-568F-4B46-8962-161359AFE7CEQ35903772-146F1544-7531-400B-B661-71E1FC1D5370Q35914820-154710BF-5D4A-4142-8788-354690D3F745Q35917482-C8EFABFC-C2FA-46C0-BC92-160CCCFFD2C9Q36486156-B5E17422-D281-4BB3-B3D4-1831181652CBQ36614706-584656D9-E346-455B-B66F-F1EE5A5D422AQ36684252-F1469987-237E-4D8E-ADD4-A8F98B0BD36AQ36787402-84F0E9A6-BFB4-4141-B25B-01732FD7D1DBQ36859567-C89EE24F-9BF8-4AA0-9869-6F5C24080D7EQ36955934-3D00E691-FA3F-4217-BDFA-DAFC36772F47
P2860
Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Paricalcitol inhibits renal in ...... tration of NF-kappaB signaling
@en
type
label
Paricalcitol inhibits renal in ...... tration of NF-kappaB signaling
@en
prefLabel
Paricalcitol inhibits renal in ...... tration of NF-kappaB signaling
@en
P2093
P2860
P921
P356
P1476
Paricalcitol inhibits renal in ...... tration of NF-kappaB signaling
@en
P2093
Xiaoyan Wen
Xiaoyue Tan
Youhua Liu
P2860
P304
P356
10.1681/ASN.2007060666
P577
2008-06-04T00:00:00Z